• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内皮功能障碍、动脉粥样硬化和血管性血友病因子及因子 VIII 的增加:猪的随机对照试验。

Endothelial Dysfunction, Atherosclerosis, and Increase of von Willebrand Factor and Factor VIII: A Randomized Controlled Trial in Swine.

机构信息

Department of Hematology, Erasmus Medical Center, University Medical Center Rotterdam, Rotterdam, The Netherlands.

Division of Experimental Cardiology, Department of Cardiology, Thoraxcenter, Erasmus Medical Center, University Medical Center Rotterdam, Rotterdam, The Netherlands.

出版信息

Thromb Haemost. 2021 May;121(5):676-686. doi: 10.1055/s-0040-1722185. Epub 2021 Jan 14.

DOI:10.1055/s-0040-1722185
PMID:33506473
Abstract

It is well known that high von Willebrand factor (VWF) and factor VIII (FVIII) levels are associated with an increased risk of cardiovascular disease. It is still debated whether VWF and FVIII are biomarkers of endothelial dysfunction and atherosclerosis or whether they have a direct causative role. Therefore, we aimed to unravel the pathophysiological pathways of increased VWF and FVIII levels associated with cardiovascular risk factors. First, we performed a randomized controlled trial in 34 Göttingen miniswine. Diabetes mellitus (DM) was induced with streptozotocin and hypercholesterolemia (HC) via a high-fat diet in 18 swine (DM + HC), while 16 healthy swine served as controls. After 5 months of follow-up, FVIII activity (FVIII:C) was significantly higher in DM + HC swine (5.85 IU/mL [5.00-6.81]) compared with controls (4.57 [3.76-5.40],  = 0.010), whereas VWF antigen (VWF:Ag) was similar (respectively 0.34 IU/mL [0.28-0.39] vs. 0.34 [0.31-0.38],  = 0.644). DM + HC swine had no endothelial dysfunction or atherosclerosis during this short-term follow-up. Subsequently, we performed a long-term (15 months) longitudinal cohort study in 10 Landrace-Yorkshire swine, in five of which HC and in five combined DM + HC were induced. VWF:Ag was higher at 15 months compared with 9 months in HC (0.37 [0.32-0.42] vs. 0.27 [0.23-0.40],  = 0.042) and DM + HC (0.33 [0.32-0.37] vs. 0.25 [0.24-0.33],  = 0.042). Both long-term groups had endothelial dysfunction compared with controls and atherosclerosis after 15 months. In conclusion, short-term hyperglycemia and dyslipidemia increase FVIII, independent of VWF. Long-term DM and HC increase VWF via endothelial dysfunction and atherosclerosis. Therefore, VWF seems to be a biomarker for advanced cardiovascular disease.

摘要

众所周知,高血管性血友病因子 (VWF) 和因子 VIII (FVIII) 水平与心血管疾病风险增加有关。目前仍存在争议,即 VWF 和 FVIII 是内皮功能障碍和动脉粥样硬化的生物标志物,还是它们具有直接的因果关系。因此,我们旨在阐明与心血管危险因素相关的 VWF 和 FVIII 水平升高的病理生理途径。首先,我们在 34 头哥廷根小型猪中进行了一项随机对照试验。18 头猪(DM+HC)用链脲佐菌素诱导糖尿病(DM),并用高脂肪饮食诱导高胆固醇血症(HC),而 16 头健康猪作为对照。随访 5 个月后,DM+HC 猪的 FVIII 活性(FVIII:C)明显高于对照组(5.85 IU/mL [5.00-6.81] 与 4.57 [3.76-5.40],  = 0.010),而 VWF 抗原(VWF:Ag)相似(分别为 0.34 IU/mL [0.28-0.39] 与 0.34 [0.31-0.38],  = 0.644)。在这个短期随访期间,DM+HC 猪没有内皮功能障碍或动脉粥样硬化。随后,我们在 10 头长白-约克夏猪中进行了一项为期 15 个月的纵向队列研究,其中 5 头猪诱导 HC,5 头猪诱导 DM+HC。与 9 个月时相比,HC(0.37 [0.32-0.42] 与 0.27 [0.23-0.40],  = 0.042)和 DM+HC(0.33 [0.32-0.37] 与 0.25 [0.24-0.33],  = 0.042)猪的 VWF:Ag 在 15 个月时更高。与对照组相比,这两个长期组在 15 个月时都出现了内皮功能障碍,并且在 15 个月时出现了动脉粥样硬化。总之,短期高血糖和血脂异常会增加 FVIII,而与 VWF 无关。长期的 DM 和 HC 通过内皮功能障碍和动脉粥样硬化增加 VWF。因此,VWF 似乎是心血管疾病进展的生物标志物。

相似文献

1
Endothelial Dysfunction, Atherosclerosis, and Increase of von Willebrand Factor and Factor VIII: A Randomized Controlled Trial in Swine.内皮功能障碍、动脉粥样硬化和血管性血友病因子及因子 VIII 的增加:猪的随机对照试验。
Thromb Haemost. 2021 May;121(5):676-686. doi: 10.1055/s-0040-1722185. Epub 2021 Jan 14.
2
Comorbidities associated with higher von Willebrand factor (VWF) levels may explain the age-related increase of VWF in von Willebrand disease.与较高 von Willebrand 因子 (VWF) 水平相关的合并症可能解释了 von Willebrand 病中 VWF 随年龄增长而增加的原因。
Br J Haematol. 2018 Jul;182(1):93-105. doi: 10.1111/bjh.15277. Epub 2018 May 16.
3
Rise of levels of von Willebrand factor and factor VIII with age: Role of genetic and acquired risk factors.随着年龄的增长,血管性血友病因子和因子 VIII 水平的升高:遗传和获得性危险因素的作用。
Thromb Res. 2021 Jan;197:172-178. doi: 10.1016/j.thromres.2020.11.016. Epub 2020 Nov 16.
4
Evaluation of von Willebrand factor phenotypes and genotypes in Hemophilia A patients with and without identified F8 mutations.对有无已鉴定出F8突变的A型血友病患者血管性血友病因子表型和基因型的评估。
J Thromb Haemost. 2015 Jun;13(6):1036-42. doi: 10.1111/jth.12902. Epub 2015 May 9.
5
Akt pathway is hypoactivated by synergistic actions of diabetes mellitus and hypercholesterolemia resulting in advanced coronary artery disease.糖尿病和高胆固醇血症的协同作用使 Akt 通路活性降低,导致严重的冠状动脉疾病。
Am J Physiol Heart Circ Physiol. 2010 Sep;299(3):H699-706. doi: 10.1152/ajpheart.00071.2010. Epub 2010 Jul 2.
6
Changes in von Willebrand factor level and von Willebrand activity with age in type 1 von Willebrand disease.1型血管性血友病患者血管性血友病因子水平及血管性血友病活性随年龄的变化
Haemophilia. 2015 Sep;21(5):636-41. doi: 10.1111/hae.12664. Epub 2015 Mar 10.
7
To serve and protect: The modulatory role of von Willebrand factor on factor VIII immunogenicity.服务与保护:血管性血友病因子对因子 VIII 免疫原性的调节作用。
Blood Rev. 2017 Sep;31(5):339-347. doi: 10.1016/j.blre.2017.07.001. Epub 2017 Jul 4.
8
Diagnosis of von Willebrand disease type 2N: a simplified method for measurement of factor VIII binding to von Willebrand factor.2N型血管性血友病的诊断:一种测量因子VIII与血管性血友病因子结合的简化方法。
Am J Hematol. 1998 Aug;58(4):311-8. doi: 10.1002/(sici)1096-8652(199808)58:4<311::aid-ajh11>3.0.co;2-a.
9
Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma.血浆中血管性血友病因子抗原、血管性血友病因子瑞斯托霉素辅因子活性与凝血因子 VIII 活性之间的相关性。
J Thromb Thrombolysis. 2008 Oct;26(2):150-3. doi: 10.1007/s11239-007-0090-0. Epub 2007 Sep 3.
10
Standardisation of factor VIII and von Willebrand factor in plasma: calibration of the 4th International Standard (97/586).血浆中凝血因子VIII和血管性血友病因子的标准化:第4个国际标准品(97/586)的校准
Thromb Haemost. 2001 Apr;85(4):634-8.

引用本文的文献

1
Silencing of the von Willebrand factor gene in proatherothrombotic transgenic mice.在促动脉粥样硬化血栓形成转基因小鼠中沉默血管性血友病因子基因。
Res Pract Thromb Haemost. 2025 Feb 6;9(1):102699. doi: 10.1016/j.rpth.2025.102699. eCollection 2025 Jan.
2
[Leuko-glycemic index as a marker of inflammation and endothelial dysfunction in overweight and obesity].[白细胞血糖指数作为超重和肥胖中炎症及内皮功能障碍的标志物]
Rev Med Inst Mex Seguro Soc. 2024 Jul 1;62(4):1-8. doi: 10.5281/zenodo.11397066.
3
Blood coagulation in Prediabetes clusters-impact on all-cause mortality in individuals undergoing coronary angiography.
糖尿病前期患者的凝血簇——对行冠状动脉造影术个体全因死亡率的影响。
Cardiovasc Diabetol. 2024 Aug 22;23(1):306. doi: 10.1186/s12933-024-02402-z.
4
Effects of subcutaneous vs. oral nanoparticle-mediated insulin delivery on hemostasis disorders in type 1 diabetes: A rat model study.皮下与口服纳米颗粒介导的胰岛素递送对1型糖尿病止血障碍的影响:一项大鼠模型研究。
Heliyon. 2024 Apr 27;10(9):e30450. doi: 10.1016/j.heliyon.2024.e30450. eCollection 2024 May 15.
5
Type 1 VWD classification revisited: novel insights from combined analysis of the LoVIC and WiN studies.再次探讨 1 型血管性血友病的分类:来自 LoVIC 和 WiN 研究联合分析的新见解。
Blood. 2024 Apr 4;143(14):1414-1424. doi: 10.1182/blood.2023022457.
6
Association of LDL-cholesterol subfractions with cardiovascular disorders: a systematic review.载脂蛋白 B 及 LDL 亚组分与心血管疾病关系的研究进展。
BMC Cardiovasc Disord. 2023 Nov 1;23(1):533. doi: 10.1186/s12872-023-03578-0.
7
Isolation of Vascular Wall Mesenchymal Stem Cells from the Thoracic Aorta of Adult Göttingen Minipigs: A New Protocol for the Simultaneous Endothelial Cell Collection.从成年哥廷根小型猪胸主动脉中分离血管壁间充质干细胞:一种同时收集内皮细胞的新方法。
Animals (Basel). 2023 Aug 12;13(16):2601. doi: 10.3390/ani13162601.
8
The Role of the Coagulation System in Peripheral Arterial Disease: Interactions with the Arterial Wall and Its Vascular Microenvironment and Implications for Rational Therapies.凝血系统在外周动脉疾病中的作用:与动脉壁及其血管微环境的相互作用以及对合理治疗的影响。
Int J Mol Sci. 2022 Nov 29;23(23):14914. doi: 10.3390/ijms232314914.
9
MicroRNA and Hemostasis Profile of Carotid Atherosclerosis.颈动脉粥样硬化的 microRNA 和止血谱。
Int J Mol Sci. 2022 Sep 19;23(18):10974. doi: 10.3390/ijms231810974.
10
Recent advances in molecular biology of metabolic syndrome pathophysiology: endothelial dysfunction as a potential therapeutic target.代谢综合征病理生理学分子生物学的最新进展:内皮功能障碍作为潜在治疗靶点
J Diabetes Metab Disord. 2022 Aug 31;21(2):1903-1911. doi: 10.1007/s40200-022-01088-y. eCollection 2022 Dec.